Drugs / platlet rich plasma
platlet rich plasma
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02660294 | Mar 2016 → Mar 2017 | infertility disorder | Ain Shams University | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT06937645 | Sep 2023 → May 2025 overdue | infertility disorder | Al-Nahrain University | Recruiting | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03986372 | Aug 2019 → Jun 2023 | disease of the tendon | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | platlet rich plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06937645 ↗ |
| Known as | Platelet-rich plasma | “Platelet-rich plasma (PRP) is prepared from fresh whole blood” NCT02660294 ↗ |
| Known as | PRP | “Platelet-rich plasma (PRP) is prepared from fresh whole blood” NCT02660294 ↗1“platlet rich plasma (PRP)” NCT06937645 ↗ |
| Route | Other | “used to wash the uterine cavity on the day of oocytes retrieval” NCT06937645 ↗ |